Otonomy (OTIC) Short Interest Ratio & Short Volume

Short interest is the volume of Otonomy shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 3,650,000 shares of OTIC short. 14.59% of Otonomy's shares are currently sold short. Learn More on Otonomy's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.59% of Otonomy's floating shares are currently sold short.

Otonomy saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 3,650,000 shares, an increase of 157.0% from the previous total of 1,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Otonomy currently has issued a total of 68,527,000 shares. Some of Otonomy's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Otonomy currently has a public float of 25,010,000 shares.

14.59% of Otonomy's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Otonomy: Entero Therapeutics, Inc. (3.00%), Eyenovia, Inc. (12.05%), Cyclacel Pharmaceuticals, Inc. (1.25%), Salarius Pharmaceuticals, Inc. (0.67%), Protagenic Therapeutics, Inc. (1.72%), Processa Pharmaceuticals, Inc. (5.96%), Galmed Pharmaceuticals Ltd. (0.25%), Eterna Therapeutics Inc. (0.47%), Pasithea Therapeutics Corp. (2.62%), Quoin Pharmaceuticals, Ltd. (0.91%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.47 billion), Suncor Energy Inc. ($2.33 billion), T. Rowe Price Group, Inc. ($2.14 billion), PG&E Co. ($1.61 billion), Etsy, Inc. ($1.56 billion), Paramount Global ($1.53 billion), Old Dominion Freight Line, Inc. ($1.49 billion), Coinbase Global, Inc. ($1.46 billion), DICK'S Sporting Goods, Inc. ($1.30 billion), and C.H. Robinson Worldwide, Inc. ($1.26 billion). View all of the most shorted stocks.

Short selling OTIC is an investing strategy that aims to generate trading profit from Otonomy as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Otonomy occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OTIC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OTIC, twice per month. The most recent reporting period available is December, 15 2022.